Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA)
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Discovery Fund”. A copy of the letter is available to download here.
Caredx Inc. (CDNA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 1,997,618 | $56,932,113 | -9% | 0.59% |
| 2. | ARK Investment Management Catherine D. Wood | 1,953,531 | $55,675,622 | -13% | 0.36% |
| 3. | BAMCO Inc. Ron Baron | 1,937,326 | $55,213,791 | -42% | 0.08% |
| 4. | Ophir Asset Management Steven Ng And Andrew Mitchell | 1,264,809 | $36,047,057 | +29% | 2.96% |
| 5. | Renaissance Technologies Jim Simons | 1,242,959 | $35,424,332 | +5% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $42.34 | 5,000 | $211,693.50 | 5,000 | 2021-11-24 | Filing | |
| $47.62 | 600 | $28,572.00 | 2,855 | 2021-11-05 | Filing | |
| $9.42 | 10,136 | $95,481.12 | 965,894 | 2018-04-26 | Filing | |
| $4.00 | 1,278 | $5,112.00 | 40,529 | 2017-10-05 | Filing | |
| $4.00 | 9,364 | $37,456.00 | 928,768 | 2017-10-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $46.29 | 20,000 | $925,700.00 | 134,061 | 2026-08-05 | Filing | |
| $46.94 | 16,000 | $750,972.80 | 42,943 | 2026-08-04 | Filing | |
| $46.75 | 500 | $23,375.00 | 106,075 | 2026-08-05 | Filing | |
| $46.15 | 2,188 | $100,974.45 | 106,575 | 2026-08-05 | Filing | |
| $47.06 | 44,700 | $2,103,497.07 | 61,738 | 2026-08-04 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,036 | $1,042,340 | 0.09% | |
| 2. | 2,660 | $172,900 | 0.01% | |
| 3. | 868 | $56,420 | 0% | |
| 4. | 689 | $44,785 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Measuring the Beat: 57 Stocks Surpassing Earnings Expectations
Academic research has consistently found that corporate earnings surprises cluster around small positive values, rather than large outperformance.
CareDx, Inc (NASDAQ:CDNA) Q1 2026 Earnings Call Transcript
CareDx, Inc (NASDAQ:CDNA) Q1 2026 Earnings Call Transcript April 28, 2026CareDx, Inc beats earnings expectations. Reported EPS is $0.34, expectations were $0.11. Operator: Hello, everyone.
10 Best Diagnostics and Research Stocks to Buy According to Analysts
In this article, we will look at the 10 best diagnostics and research stocks to buy according to analysts.
CareDx, Inc (NASDAQ:CDNA) Q4 2025 Earnings Call Transcript
CareDx, Inc (NASDAQ:CDNA) Q4 2025 Earnings Call Transcript February 24, 2026CareDx, Inc misses on earnings expectations. Reported EPS is $-0.08037 EPS, expectations were $0.24.
CareDx, Inc (NASDAQ:CDNA) Q3 2025 Earnings Call Transcript
CareDx, Inc (NASDAQ:CDNA) Q3 2025 Earnings Call Transcript November 4, 2025CareDx, Inc beats earnings expectations. Reported EPS is $0.28, expectations were $0.13.
CareDx, Inc (NASDAQ:CDNA) Q2 2025 Earnings Call Transcript
CareDx, Inc (NASDAQ:CDNA) Q2 2025 Earnings Call Transcript August 6, 2025CareDx, Inc misses on earnings expectations. Reported EPS is $0.1 EPS, expectations were $0.12.
CareDx, Inc (NASDAQ:CDNA) Q1 2025 Earnings Call Transcript
CareDx, Inc (NASDAQ:CDNA) Q1 2025 Earnings Call Transcript April 30, 2025CareDx, Inc beats earnings expectations. Reported EPS is $0.09, expectations were $0.06.
CareDx, Inc (NASDAQ:CDNA) Q4 2024 Earnings Call Transcript
CareDx, Inc (NASDAQ:CDNA) Q4 2024 Earnings Call Transcript February 26, 2025CareDx, Inc beats earnings expectations. Reported EPS is $0.18, expectations were $0.05. Operator: Good afternoon, everyone.
CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S.
Hedge Fund Resource Center